Traveler’s Diarrhea Therapeutics Market Report

Global Traveler’s Diarrhea Therapeutics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：146
  • REPORT CODE：GMM857350
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Traveler’s Diarrhea Therapeutics market report explains the definition, types, applications, major countries, and major players of the Traveler’s Diarrhea Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Otsuka Pharma

    • Valneva

    • Johnson & Johnson

    • Salix Pharmaceuticals

    • Shanghai United Cell

    • P&G

    By Type:

    • Immunization

    • Non-antibiotic Agents

    • Antibiotics

    • Anti-motility Agents

    • Other

    By End-User:

    • Adult Traveler's Diarrhea

    • Children Traveler's Diarrhea

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Traveler’s Diarrhea Therapeutics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Traveler’s Diarrhea Therapeutics Outlook to 2028- Original Forecasts

    • 2.2 Traveler’s Diarrhea Therapeutics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Traveler’s Diarrhea Therapeutics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Traveler’s Diarrhea Therapeutics Market- Recent Developments

    • 6.1 Traveler’s Diarrhea Therapeutics Market News and Developments

    • 6.2 Traveler’s Diarrhea Therapeutics Market Deals Landscape

    7 Traveler’s Diarrhea Therapeutics Raw Materials and Cost Structure Analysis

    • 7.1 Traveler’s Diarrhea Therapeutics Key Raw Materials

    • 7.2 Traveler’s Diarrhea Therapeutics Price Trend of Key Raw Materials

    • 7.3 Traveler’s Diarrhea Therapeutics Key Suppliers of Raw Materials

    • 7.4 Traveler’s Diarrhea Therapeutics Market Concentration Rate of Raw Materials

    • 7.5 Traveler’s Diarrhea Therapeutics Cost Structure Analysis

      • 7.5.1 Traveler’s Diarrhea Therapeutics Raw Materials Analysis

      • 7.5.2 Traveler’s Diarrhea Therapeutics Labor Cost Analysis

      • 7.5.3 Traveler’s Diarrhea Therapeutics Manufacturing Expenses Analysis

    8 Global Traveler’s Diarrhea Therapeutics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Traveler’s Diarrhea Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Traveler’s Diarrhea Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Traveler’s Diarrhea Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Traveler’s Diarrhea Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunization Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-antibiotic Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antibiotics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Anti-motility Agents Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Traveler’s Diarrhea Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Children Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Traveler’s Diarrhea Therapeutics Market Analysis and Outlook till 2022

    • 10.1 Global Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.2.2 Canada Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.2.3 Mexico Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.2 UK Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.3 Spain Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.4 Belgium Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.5 France Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.6 Italy Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.7 Denmark Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.8 Finland Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.9 Norway Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.10 Sweden Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.11 Poland Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.12 Russia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.3.13 Turkey Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.2 Japan Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.3 India Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.4 South Korea Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.5 Pakistan Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.6 Bangladesh Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.7 Indonesia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.8 Thailand Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.9 Singapore Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.10 Malaysia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.11 Philippines Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.4.12 Vietnam Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.2 Colombia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.3 Chile Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.4 Argentina Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.5 Venezuela Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.6 Peru Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.5.8 Ecuador Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.6.2 Kuwait Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.6.3 Oman Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.6.4 Qatar Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.7.2 South Africa Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.7.3 Egypt Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.7.4 Algeria Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

      • 10.8.2 New Zealand Traveler’s Diarrhea Therapeutics Consumption (2017-2022)

    11 Global Traveler’s Diarrhea Therapeutics Competitive Analysis

    • 11.1 Otsuka Pharma

      • 11.1.1 Otsuka Pharma Company Details

      • 11.1.2 Otsuka Pharma Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Otsuka Pharma Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.1.4 Otsuka Pharma Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Valneva

      • 11.2.1 Valneva Company Details

      • 11.2.2 Valneva Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Valneva Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.2.4 Valneva Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Johnson & Johnson

      • 11.3.1 Johnson & Johnson Company Details

      • 11.3.2 Johnson & Johnson Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Johnson & Johnson Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.3.4 Johnson & Johnson Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Salix Pharmaceuticals

      • 11.4.1 Salix Pharmaceuticals Company Details

      • 11.4.2 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.4.4 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Shanghai United Cell

      • 11.5.1 Shanghai United Cell Company Details

      • 11.5.2 Shanghai United Cell Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Shanghai United Cell Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.5.4 Shanghai United Cell Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 P&G

      • 11.6.1 P&G Company Details

      • 11.6.2 P&G Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 P&G Traveler’s Diarrhea Therapeutics Main Business and Markets Served

      • 11.6.4 P&G Traveler’s Diarrhea Therapeutics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Traveler’s Diarrhea Therapeutics Market Outlook by Types and Applications to 2028

    • 12.1 Global Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Immunization Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Non-antibiotic Agents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Anti-motility Agents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adult Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Children Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Traveler’s Diarrhea Therapeutics Market Analysis and Outlook to 2028

    • 13.1 Global Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.2 UK Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.5 France Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.3 India Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Traveler’s Diarrhea Therapeutics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Traveler’s Diarrhea Therapeutics

    • Figure of Traveler’s Diarrhea Therapeutics Picture

    • Table Global Traveler’s Diarrhea Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Traveler’s Diarrhea Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Immunization Consumption and Growth Rate (2017-2022)

    • Figure Global Non-antibiotic Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotics Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-motility Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Global Children Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Global Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Table North America Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure United States Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Canada Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure Germany Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure UK Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Spain Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure France Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Italy Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Finland Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Norway Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Poland Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Russia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table APAC Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure China Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table South America Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure Brazil Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Chile Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Peru Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table GCC Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure Bahrain Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Oman Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Africa Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure Nigeria Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Oceania Traveler’s Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure Australia Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Traveler’s Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Otsuka Pharma Company Details

    • Table Otsuka Pharma Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Pharma Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table Otsuka Pharma Traveler’s Diarrhea Therapeutics Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table Valneva Traveler’s Diarrhea Therapeutics Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table Johnson & Johnson Traveler’s Diarrhea Therapeutics Product Portfolio

    • Table Salix Pharmaceuticals Company Details

    • Table Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Product Portfolio

    • Table Shanghai United Cell Company Details

    • Table Shanghai United Cell Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai United Cell Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table Shanghai United Cell Traveler’s Diarrhea Therapeutics Product Portfolio

    • Table P&G Company Details

    • Table P&G Traveler’s Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table P&G Traveler’s Diarrhea Therapeutics Main Business and Markets Served

    • Table P&G Traveler’s Diarrhea Therapeutics Product Portfolio

    • Figure Global Immunization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-antibiotic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-motility Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Table North America Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Germany Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure China Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Traveler’s Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Australia Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Traveler’s Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US